119 related articles for article (PubMed ID: 22653742)
1. Urinary 5-HIAA excretion is not increased in patients with head and neck paragangliomas.
van Hulsteijn LT; van Duinen N; Romijn JA; Smit JW; Corssmit EP
Int J Biol Markers; 2012 Jul; 27(2):e160-3. PubMed ID: 22653742
[TBL] [Abstract][Full Text] [Related]
2. Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas.
van Duinen N; Steenvoorden D; Kema IP; Jansen JC; Vriends AH; Bayley JP; Smit JW; Romijn JA; Corssmit EP
J Clin Endocrinol Metab; 2010 Jan; 95(1):209-14. PubMed ID: 19897674
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
van Duinen N; Corssmit EP; de Jong WH; Brookman D; Kema IP; Romijn JA
Eur J Endocrinol; 2013 Sep; 169(3):377-82. PubMed ID: 23832865
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas.
van Houtum WH; Corssmit EP; Douwes Dekker PB; Jansen JC; van der Mey AG; Bröcker-Vriends AH; Taschner PE; Losekoot M; Frölich M; Stokkel MP; Cornelisse CJ; Romijn JA
Eur J Endocrinol; 2005 Jan; 152(1):87-94. PubMed ID: 15762191
[TBL] [Abstract][Full Text] [Related]
5. Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue.
Osinga TE; Korpershoek E; de Krijger RR; Kerstens MN; Dullaart RP; Kema IP; van der Laan BF; van der Horst-Schrivers AN; Links TP
Neuroendocrinology; 2015; 101(4):289-95. PubMed ID: 25677368
[TBL] [Abstract][Full Text] [Related]
6. Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.
Richter S; Qiu B; Ghering M; Kunath C; Constantinescu G; Luths C; Pamporaki C; Bechmann N; Meuter L; Kwapiszewska A; Deutschbein T; Nölting S; Peitzsch M; Robledo M; Prejbisz A; Pacak K; Gudziol V; Timmers HJLM; Eisenhofer G
Endocr Relat Cancer; 2022 Mar; 29(4):213-224. PubMed ID: 35171114
[TBL] [Abstract][Full Text] [Related]
7. Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours.
Zandee WT; Kamp K; van Adrichem RC; Feelders RA; de Herder WW
Eur J Endocrinol; 2016 Nov; 175(5):361-6. PubMed ID: 27491374
[TBL] [Abstract][Full Text] [Related]
8. Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intake.
Joy T; Walsh G; Tokmakejian S; Van Uum SH
Can J Gastroenterol; 2008 Jan; 22(1):49-53. PubMed ID: 18209781
[TBL] [Abstract][Full Text] [Related]
9. 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.
Koopmans KP; Jager PL; Kema IP; Kerstens MN; Albers F; Dullaart RP
J Nucl Med; 2008 Aug; 49(8):1232-7. PubMed ID: 18632829
[TBL] [Abstract][Full Text] [Related]
10. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
[TBL] [Abstract][Full Text] [Related]
11. Dopamine excess in patients with head and neck paragangliomas.
Van Der Horst-Schrivers AN; Osinga TE; Kema IP; Van Der Laan BF; Dullaart RP
Anticancer Res; 2010 Dec; 30(12):5153-8. PubMed ID: 21187504
[TBL] [Abstract][Full Text] [Related]
12. 5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients.
van Dijk SC; de Herder WW; Kwekkeboom DJ; Zillikens MC; Feelders RA; van Schaik RH; van Driel M; van Leeuwen JP
Bone; 2012 Jun; 50(6):1260-5. PubMed ID: 22425693
[TBL] [Abstract][Full Text] [Related]
13. Carcinoid tumor of the jugulo-tympanic region.
Mandigers CM; van Gils AP; Derksen J; van der Mey AG; Hogendoorn PC
J Nucl Med; 1996 Feb; 37(2):270-2. PubMed ID: 8667059
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of paragangliomas.
Corssmit EP; Romijn JA
Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
[TBL] [Abstract][Full Text] [Related]
15. Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.
Kema IP; de Vries EG; Schellings AM; Postmus PE; Muskiet FA
Clin Chem; 1992 Apr; 38(4):534-40. PubMed ID: 1373675
[TBL] [Abstract][Full Text] [Related]
16. Urinary serotonin in the diagnosis of carcinoid tumors.
Feldman JM
Clin Chem; 1986 May; 32(5):840-4. PubMed ID: 2421946
[TBL] [Abstract][Full Text] [Related]
17. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
18. Determination of urinary 5-hydroxyindoleacetic acid as a metabolomics in gastric cancer.
Mokhtari M; Rezaei A; Ghasemi A
J Gastrointest Cancer; 2015 Jun; 46(2):138-42. PubMed ID: 25761643
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluating the prevalence and factors characteristic of catecholamine secreting head and neck paragangliomas.
Smith JD; Ellsperman SE; Basura GJ; Else T
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00256. PubMed ID: 34277980
[TBL] [Abstract][Full Text] [Related]
20. Acidic catecholamine metabolites and 5-hydroxyindoleacetic acid in urine: the influence of diet.
Mashige F; Matsushima Y; Kanazawa H; Sakuma I; Takai N; Bessho F; Ohkubo A
Ann Clin Biochem; 1996 Jan; 33 ( Pt 1)():43-9. PubMed ID: 8929065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
